Erratum
for
Romaguera et al., J Clin Oncol 23 (28) 7013-7023.
Journal of Clinical Oncology, Vol 24, No 4 (February 1), 2006: pp. 724
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.12.002
ERRATUM
The October 1, 2005, article by Romaguera et al titled, "High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine" (J Clin Oncol 23:7013-7023, 2005) contained inaccurate information in Table 4 as follows:
Whereas the overall 3-year FFS was given as 65%, it should have read 64%.
Whereas the 3-year FFS of age > 65 years (No) was given as 75%, it should have read 73%.
Whereas the P value for age > 65 years (No) was given as .01, it should have read .02.
Whereas the 3-year OS for age > 65 years (No) was given as 85%, it should have read 86%.
Whereas the 3-year OS for age > 65 years (Yes) was given as 75%, it should have read 74%.
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
|
